Very low energy ketogenic therapy + liraglutide

Very low energy ketogenic therapy + liraglutide has been studied in 1 paper since 2025: 1 trial in people. The newest paper, Oct 22, 2025: “SUN-675 Very Low Energy Ketogenic Therapy In Combination With Liraglutide As A Synergic Strategy For The Treatment Of Obesity: A Real-world Clinical Evaluation”.

Intervention

1 paper studies it4 findingsUpdated

See all 1 papers on very low energy ketogenic therapy + liraglutide

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“However, the VLEKT +Lira group experienced greater weight loss (-20.4% vs -14.7%, p = 0.013)”
SUN-675 Very Low Energy Ketogenic Therapy In Combination With Liraglutide As A Synergic Strategy For The Treatment Of Obesity: A Real-world Clinical EvaluationENDO 2025 abstract2025doi:10.1210/jendso/bvaf149.185

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Human trial1

Studies in people

1 study gave very low energy ketogenic therapy + liraglutide to people and measured what changed.

What changedDesignPeopleSource

down: Decreases body weight-20.4% vs -14.7%, p = 0.013

down: Decreases insulin resistancep<0.001

up: Increases ketone

Treated cohortfour-monthPatient cohortsENDO 2025 abstract, Oct 22, 2025

What did studies of very low energy ketogenic therapy + liraglutide find?

4

Studies of very low energy ketogenic therapy + liraglutide measured 4 outcomes, among them nausea, ketone and insulin resistance.

Nausea

upin humans1

1 study
  1. Very low energy ketogenic therapy + liraglutide is linked with higher nausea in humans (p<0.001).

    “Despite the metabolic benefits, the VLEKT +Lira group reported a higher incidence of adverse effects, including nausea (p<0.001), heartburn (0.004), reflux (p=0.009)”

    Humansfour-month

    SUN-675 Very Low Energy Ketogenic Therapy In Combination With Liraglutide As A Synergic Strategy For The Treatment Of Obesity: A Real-world Clinical Evaluation

    ENDO 2025 abstract

Ketone

upin humans1

1 study
  1. Very low energy ketogenic therapy + liraglutide is linked with higher ketone in humans.

    “Ketone levels were higher in the combination group, suggesting improved adherence to the dietary regimen.”

    Humansfour-month

    SUN-675 Very Low Energy Ketogenic Therapy In Combination With Liraglutide As A Synergic Strategy For The Treatment Of Obesity: A Real-world Clinical Evaluation

    ENDO 2025 abstract

More on Ketone

Insulin resistance

downin humans1

1 study
  1. Very low energy ketogenic therapy + liraglutide is linked with lower insulin resistance in humans (p<0.001).

    “and a more pronounced reduction in insulin resistance (p<0.001).”

    Humansfour-month

    SUN-675 Very Low Energy Ketogenic Therapy In Combination With Liraglutide As A Synergic Strategy For The Treatment Of Obesity: A Real-world Clinical Evaluation

    ENDO 2025 abstract

More on Insulin resistance

Body weight

downin humans1

1 study
  1. Very low energy ketogenic therapy + liraglutide is linked with lower body weight in humans (-20.4% vs -14.7%, p = 0.013).

    “However, the VLEKT +Lira group experienced greater weight loss (-20.4% vs -14.7%, p = 0.013)”

    Humansfour-month

    SUN-675 Very Low Energy Ketogenic Therapy In Combination With Liraglutide As A Synergic Strategy For The Treatment Of Obesity: A Real-world Clinical Evaluation

    ENDO 2025 abstract

Latest